Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Craig Buchman

Plastic Surgery within the Head & Neck Saint Louis, MO Medical Doctor

NPI 1538260120 CMS profile 160658

4921 Parkview Pl, Dept Otolaryngology, Ste 11A, Saint Louis, MO 63110

Open in the dashboard

General payments

$533,603

101 records reported · program years 2019–2025

Research payments

$1,149

Paid to them · 4 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$46,651 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Craig Buchman of Saint Louis, MO is reported in the CMS Open Payments database as having received $533,603 across 101 general payments and $1,149 in research payments paid to them. Separately, studies naming them as principal investigator received $46,651 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Plastic Surgery within the Head & Neck profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $84,235 19
2024 General $25,696 27
2023 General $63,947 13
2022 General $60,153 6
2021 General $70,583 5
2020 General $98,423 11
2019 General $130,565 20
2019 Research $1,149 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Craig Buchman
  • Plastic Surgery within the Head & Neck median
  • Middle half of Plastic Surgery within the Head & Neck
  • National median

In program year 2025, general payments to Craig Buchman were reported at $84,235. Among 399 Plastic Surgery within the Head & Neck profiles paid that year, the median was $237 and the middle half received between $103 and $520.

Show as a table
Year Craig Buchman Plastic Surgery within the Head & Neck median Middle half National median
2019 $130,565 $200 $82–$550 $163
2020 $98,423 $120 $46–$330 $114
2021 $70,583 $166 $60–$382 $132
2022 $60,153 $208 $83–$530 $149
2023 $63,947 $202 $77–$538 $160
2024 $25,696 $260 $99–$645 $164
2025 $84,235 $237 $103–$520 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Advanced Bionics, LLC $463,752 23 payments
  2. Cochlear Americas $55,491 62 payments
  3. MED-EL Corporation $6,268 6 payments
  4. iotaMotion, Inc $6,224 3 payments
  5. Cochlear Ltd $1,552 2 payments
  6. Grace Medical, Inc. $162 2 payments
  7. Medtronic, Inc. $136 2 payments
  8. Olympus America Inc. $18 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $332,471 6 payments
  2. Consulting Fee $162,743 19 payments
  3. Travel and Lodging $27,578 25 payments
  4. Grant $6,000 1 payment
  5. Food and Beverage $4,810 50 payments
Products named General payments · program years 2019–2025
  1. HiResolution Bionic Ear System $226,570 15 payments
  2. HIRES ULTRA CI HIFOCUS MS ELECTRODE Otolaryngology $172,747 6 payments
  3. HIRES ULTRA CI HIFOCUS MS ELECTRODE Otolaryngology $64,435 2 payments
  4. BAHA Implantable hearing solution $54,924 54 payments
  5. Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode $54,665 52 payments
  6. OSIA OSI300 IMPLANT $54,516 50 payments
  7. MED-EL Maestro Cochlear Implant System $6,000 1 payment
  8. iotaSOFT Insertion System $4,375 1 payment
  9. Nucleus $1,970 8 payments
  10. Baha Implantable hearing solution $1,970 8 payments
  11. Other $3,385 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Cochlear Americas $1,149 4 payments

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

45

Median for Otolaryngology: 297

Drug cost

$868

Median for Otolaryngology: $6,314

Branded share of claims

33.3%

Median for Otolaryngology: 10.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ofloxacin Generic 30 $765
Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid Brand 15 $104

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 9,296 Part D prescribers listed as Otolaryngology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$24,529

Medicare's payments for the services billed

Medicare patients

113

Average age 72

Services billed

173

67 women, 46 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 66%
Arthritis 52%
Diabetes 26%
Ischemic heart disease 20%
Chronic kidney disease 19%
Depression 19%
COPD 16%
Atrial fibrillation 15%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

105 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery within the Head & Neck in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record